Vaxart Inc. (NASDAQ:VXRT) has a beta value of 0.81 and has seen 1.72 million shares traded in the last trading session. The company, currently valued at $135.41M, closed the last trade at $1.10 per share which meant it lost -$0.03 on the day or -2.65% during that session. The VXRT stock price is -393.64% off its 52-week high price of $5.43 and 33.64% above the 52-week low of $0.73. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.14 million shares traded. The 3-month trading volume is 3.49 million shares.
The consensus among analysts is that Vaxart Inc. (VXRT) is an Overweight stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 4 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.24.
Vaxart Inc. (NASDAQ:VXRT) trade information
Sporting -2.65% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on Monday, 01/23/23 when the VXRT stock price touched $1.10 or saw a rise of 8.33%. Year-to-date, Vaxart Inc. shares have moved 14.48%, while the 5-day performance has seen it change -5.98%. Over the past 30 days, the shares of Vaxart Inc. (NASDAQ:VXRT) have changed 18.98%. Short interest in the company has seen 24.5 million shares shorted with days to cover at 7.71.
Wall Street analysts have a consensus price target for the stock at $6.13, which means that the shares’ value could jump 82.06% from current levels. The projected low price target is $1.50 while the price target rests at a high of $10.00. In that case, then, we find that the current price level is -809.09% off the targeted high while a plunge would see the stock gain -36.36% from current levels.
Vaxart Inc. (VXRT) estimates and forecasts
Figures show that Vaxart Inc. shares have underperformed across the wider relevant industry. The company’s shares have lost -70.59% over the past 6 months, with this year growth rate of -44.83%, compared to 11.30% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2023 fiscal year revenue. Growth estimates for the current quarter are -71.40% and -35.30% for the next quarter. Revenue growth from the last financial year stood is estimated to be 11.00%.
3 analysts offering their estimates for the company have set an average revenue estimate of $70k for the current quarter. 4 have an estimated revenue figure of $670k for the next quarter concluding in Dec 2022. Year-ago sales stood $270k and $74k respectively for this quarter and the next, and analysts expect sales will shrink by -74.10% for the current quarter and 805.40% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 41.40% over the past 5 years.
Vaxart Inc. is expected to release its next earnings report between February 22 and February 27 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Vaxart Inc. (NASDAQ:VXRT)’s Major holders
Insiders own 0.87% of the company shares, while shares held by institutions stand at 36.07% with a share float percentage of 36.39%. Investors are also buoyed by the number of investors in a company, with Vaxart Inc. having a total of 209 institutions that hold shares in the company. The top two institutional holders are State Street Corporation with over 12.67 million shares worth more than $44.35 million. As of Jun 29, 2022, State Street Corporation held 10.02% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 9.18 million shares as of Jun 29, 2022. The firm’s total holdings are worth over $32.14 million and represent 7.26% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund. As of Sep 29, 2022, the former fund manager holds about 9.04% shares in the company for having 11.44 million shares of worth $24.94 million while later fund manager owns 3.74 million shares of worth $13.08 million as of Jun 29, 2022, which makes it owner of about 2.95% of company’s outstanding stock.